Repare Therapeutics Announces a Strategic Partnership Agreement with ONO Pharmaceutical Co., Ltd. for Repare’s Polθ Inhibitor Program in Japan and Selected Territories in Asia
Read MoreThe BIOQuébec network consists of more than 100 life sciences industry members.Discover more about NMX Research and Solutions in its profile!
Read MoreThe BIOQuébec network consists of more than 100 life sciences industry members.Discover more about NMX Research and Solutions in its profile!
Read MoreVantage Biotrials volunteered for a pilot Health Canada inspection program. Discover how it distinguished itself as a model of excellence.
Read MoreIs innovation in health and life sciences an issue that resonates with you? Make your voice heard today!
Read MoreSo if Fisher Scientific, through its rebates, covered the cost of your annual BIOQuébec fees, would you be a member? That’s the case for several existing members!
Read MoreSanta's not the only spy on the go. That's why one biotech company in St. John's treated its employees to webcam covers — and they gave them out to clients, too.
Read MoreNot surprisingly, established players continue to invest in 3D-printing research, while newer manufacturers are also breaking into the pharmaceutical space. An article by Jerry Martin.
Read MoreClinical research is sparking change that matters by Doug Peddicord
Read More6000 persons were interviewed in this pan-European study which was led by the ORION partners VA in Sweden and CEITEC in the Czech Republic. The full report is now published.
Read More“Canada provides us access to another geography with exceptionally strong academic science. Despite this top-tier scientific infrastructure, the venture and startup ecosystem has not grown at the same pace,” said Brad Bolzon, Ph.D., managing director and chair of the investment team at Versant.
Read MoreIn a world where it seems like startups are created every other day and market economics remain largely unpredictable, securing funding for your biotech startup can prove to be an arduous task.
Read MoreAs everybody knows by now, words matter in politics as well as in science. Here is a brief account of how this new focus came about and how it led up to a new thematic series now fully published in Life Sciences, Society and Policy.
Read MorePharma production is ‘too conservative’ and needs to ‘be bolder’ in adopting nascent technologies, or be left behind by new models, suggested one MD. An article from Ben Hargreaves
Read MoreScheduled to visit from November 26 to 30, the delegation will travel to the cities of Bengaluru and Mumbai. The focus of this visit is the Information and Communication Technology (ICT) and life sciences industry.
Read MoreYour chance to win two passes to Effervescence2019!
Read MoreThe agreement reached between IMC (then Rx&D) and BIOQuébec in 2013, which offers some members of BIOQuébec the opportunity to become a member of IMC for an amount equivalent to 20% of their BIOQuébec membership, will be renewed.
Read MoreWe call certain technologies “disruptive” for good reason: they can disrupt not only markets, but also people and societies. Most emerging technologies, however, also hold the promise of substantial social benefit.
Read MoreWe call certain technologies “disruptive” for good reason: they can disrupt not only markets, but also people and societies. Most emerging technologies, however, also hold the promise of substantial social benefit.
Read MoreKendall Square in Cambridge, Massachusetts, represents a near-perfect marriage of technology, science, and capitalism. Butting right up against MIT and down the street from Harvard, the square boasts gleaming high-rises built by Pfizer, Biogen, and Akamai, offices with outposts for Google, Facebook, and Twitter, and thriving incubators and accelerators including Cogo Labs and MIT’s the Engine. In 2009, the Boston Consulting Group called it “the most innovative square mile on earth.”
Read More